Literature DB >> 3193462

Magnesium deficiency exacerbates and pretreatment improves outcome following traumatic brain injury in rats: 31P magnetic resonance spectroscopy and behavioral studies.

T K McIntosh1, A I Faden, I Yamakami, R Vink.   

Abstract

The biochemical mechanisms mediating delayed or secondary tissue injury after central nervous system trauma remain speculative. We have demonstrated previously that traumatic brain injury in rats causes a rapid decline in tissue intracellular free magnesium [Mg]f and total magnesium [Mg]t concentrations, which were significantly correlated with injury severity. In order to examine the relationship between magnesium and traumatic brain injury, we assessed whether (1) magnesium deficiency exacerbates or (2) magnesium treatment improves posttraumatic outcome following fluid-percussion brain injury (2.0-2.4 atm) in rats. Animals placed on magnesium-deficient diet for 14 days showed a 15% decrease in brain [Mg]f as measured by phosphorus (31P) magnetic resonance spectroscopy (MRS). Magnesium deficiency significantly exacerbated neurologic dysfunction and increased mortality following injury when compared to normally fed saline-treated controls. Conversely, pretreatment with magnesium sulfate (0.1 mEq) 15 min before brain injury prevented the fall in [Mg]f observed by 31P MRS in saline-treated animals and significantly improved both cellular bioenergetic state and chronic posttraumatic neurologic outcome. These combined observations suggest that alterations in brain [Mg]f after trauma may play a role in the pathophysiology of traumatic brain injury.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3193462     DOI: 10.1089/neu.1988.5.17

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  18 in total

Review 1.  A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury.

Authors:  Kevin W McConeghy; Jimmi Hatton; Lindsey Hughes; Aaron M Cook
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

Review 2.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

3.  When basic research doesn't translate to the bedside--lessons from the magnesium brain trauma study.

Authors:  John W Miller; Raimondo D'Ambrosio
Journal:  Epilepsy Curr       Date:  2007 Sep-Oct       Impact factor: 7.500

4.  The law and the laboratory.

Authors:  Roger W Byard; Robert Vink
Journal:  Forensic Sci Med Pathol       Date:  2013-02-23       Impact factor: 2.007

5.  Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage.

Authors:  Frederic P Collignon; Jonathan A Friedman; David G Piepgras; Mark A Pichelmann; Jon I McIver; L Gerard Toussaint; Robyn L McClelland
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 6.  Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?

Authors:  Niklas Marklund; Lars Hillered
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

7.  Magnesium sulphate only slightly reduces the shivering threshold in humans.

Authors:  A Wadhwa; P Sengupta; J Durrani; O Akça; R Lenhardt; D I Sessler; A G Doufas
Journal:  Br J Anaesth       Date:  2005-03-04       Impact factor: 9.166

Review 8.  Diet, ketones, and neurotrauma.

Authors:  Mayumi Prins
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

Review 9.  Pharmacology of traumatic brain injury: where is the "golden bullet"?

Authors:  Kathryn Beauchamp; Haitham Mutlak; Wade R Smith; Esther Shohami; Philip F Stahel
Journal:  Mol Med       Date:  2008-08-18       Impact factor: 6.354

10.  The Neurometabolic Cascade of Concussion.

Authors:  Christopher C. Giza; David A. Hovda
Journal:  J Athl Train       Date:  2001-09       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.